Phase 3Recruiting
(Peak) A Phase 3 Randomized Trial of Bezuclastinib (CGT9486)+Sunitinib vs. Sunitinib in Participants With Gastrointestinal Stromal Tumors
A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
- Sponsor
- Cogent Biosciences, Inc. (Industry)
- Enrollment
- 482 planned
- Conditions
- Advanced Gastrointestinal Stromal Tumors; Metastatic Cancer
- Interventions
- Bezuclastinib; Bezuclastinib; Sunitinib; Sunitinib; Midazolam; Bezuclastinib; Sunitinib; Bezuclastinib; Sunitinib
- Ages
- adults, older adults
- Registry
- NCT05208047
Full record on ClinicalTrials.gov
From the registry
This is a Phase 3, open-label, international, multicenter study of bezuclastinib in combination with sunitinib. This is a multi-part study that will enroll approximately 482 participants. Part 1 consists of two evaluations: 1) confirming the dose of an updated formulation of bezuclastinib to be used in subsequent parts in approximately 20 participants who have received at least one prior line of therapy for Gastrointestinal Stromal Tumors (GIST) and 2) evaluating the potential for drug-drug interactions between bezuclastinib and sunitinib in approximately 18 participants who have received at least two prior tyrosine kinase inhibitors (TKIs) for GISTs. The second part of the study will enroll approximately 388 participants who are intolerant to, or who failed prior treatment with imatinib only and will compare the efficacy of bezuclastinib plus sunitinib to sunitinib alone with participants being randomized in a 1:1 manner. This study also contains two substudies: 1) a drug-drug interactions (DDI) substudy will investigate the potential for bezuclastinib to be a Cytochrome P450…
Primary outcomes
- Part 1a - pharmacokinetics - Cmax
- Part 1a - pharmacokinetics - AUC
- Part 1b - pharmacokinetics - Cmax
- Part 1b - pharmacokinetics - AUC
History
Study completion expected
Last registry update
Primary completion
Started
Registered